Original Research
Published on 23 Feb 2026
Adherence to adjuvant endocrine therapy in breast cancer: a single regional Australian centre experience
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1704927
- 279 views
18 articles related to "Adjuvant Endocrine Therapy"
Articles
Original Research
Published on 12 Jan 2023
Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor–positive breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.996522
- 2,102 views
- 3 citations
Review
Published on 04 Sep 2018
An Update on Breast Cancer Multigene Prognostic Tests—Emergent Clinical Biomarkers
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2018.00248
- 38,540 views
- 162 citations
Systematic Review
Published on 30 May 2022
Efficacy and Safety of Initial 5Â Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.886954
- 5,089 views
- 2 citations
Original Research
Published on 23 Jun 2022
Association of Molecular Biomarker Heterogeneity With Treatment Pattern and Disease Outcomes in Multifocal or Multicentric Breast Cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.833093
- 3,213 views
- 11 citations
Original Research
Published on 27 Oct 2022
Extended adjuvant endocrine therapy for women with hormone receptor-positive early breast cancer: A meta-analysis with trial sequential analysis of randomized controlled trials
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1039320
- 5,546 views
- 15 citations
Original Research
Published on 26 Oct 2022
Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1032166
- 4,857 views
- 5 citations
Case Report
Published on 17 Jun 2025
Diffuse large B-cell lymphoma combined with two solid tumors: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1561923
- 1,868 views
Original Research
Published on 27 Jul 2023
Fear of cancer recurrence in South Korean survivors of breast cancer who have received adjuvant endocrine therapy: a cross-sectional study
in Psycho-Oncology
Frontiers in Psychology
doi 10.3389/fpsyg.2023.1170077
- 3,507 views
- 6 citations
Case Report
Published on 03 Sep 2025
Primary mucinous carcinoma of the skin with co-expression of TRPS1 and GATA3: a case report
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1530871
- 2,727 views
Original Research
Published on 05 Sep 2022
Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.886831
- 6,555 views
- 3 citations
Original Research
Published on 06 Jul 2023
Investigation on sexual function in young breast cancer patients during endocrine therapy: a latent class analysis
in Precision Medicine
Frontiers in Medicine
doi 10.3389/fmed.2023.1218369
- 3,768 views
- 5 citations
Case Report
Published on 26 Jan 2026
Case Report: Mixed ductal–lobular carcinoma consisting of invasive lobular carcinoma with a glycogen-rich clear cell pattern and elevated tumor mutation burden
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1741727
- 680 views
Original Research
Published on 27 Sep 2022
Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.889695
- 2,889 views
- 1 citation
Original Research
Published on 05 May 2022
Association of Obesity and Luminal Subtypes in Prognosis and Adjuvant Endocrine Treatment Effectiveness Prediction in Chinese Breast Cancer Patients
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.862224
- 3,407 views
- 9 citations
Original Research
Published on 19 Nov 2021
Evaluating the Risk of Breast Cancer Recurrence and Metastasis After Adjuvant Tamoxifen Therapy by Integrating Polymorphisms in Cytochrome P450 Genes and Clinicopathological Characteristics
in Cancer Imaging and Image-directed Interventions
Frontiers in Oncology
doi 10.3389/fonc.2021.738222
- 5,033 views
- 3 citations